Intermediate Access Protocol
Showing 1 - 25 of >10,000
Parkinson Disease Trial (HB- adMSCs (Hope Biosciences adipose derived mesenchymal stem cells))
Available
- Parkinson Disease
- HB- adMSCs (Hope Biosciences adipose derived mesenchymal stem cells)
- (no location specified)
Sep 20, 2023
Dravet Syndrome, Lennox Gastaut Syndrome, Developmental and Epileptic Encephalopathies Trial run by the Longboard
Available
- Dravet Syndrome
- +2 more
-
Bethesda, MarylandMid-Atlantic Epilepsy and Sleep Center
Nov 19, 2023
Post COVID-19 Syndrome Trial in Sugar Land (HB-adMSCs)
No longer available
- Post COVID-19 Syndrome
- HB-adMSCs
-
Sugar Land, TexasHope Biosciences Stem Cell Research Foundation
Nov 1, 2022
Multiple System Atrophy (MSA) Trial in Morrisville (BHV3241, verdiperstat)
No longer available
- Multiple System Atrophy (MSA)
- BHV3241, verdiperstat
-
Morrisville, North CarolinaPPD
Oct 4, 2022
Amyotrophic Lateral Sclerosis Trial in Boston (CNM-Au8)
Available
- Amyotrophic Lateral Sclerosis
-
Boston, MassachusettsMassachusetts General Hospital
Mar 9, 2022
Amyotrophic Lateral Sclerosis Trial in Boston (Trehalose)
Temporarily not available
- Amyotrophic Lateral Sclerosis
-
Boston, MassachusettsSean M. Healey & AMG Center for ALS Neurological Clinical Resear
Dec 14, 2022
NSCLC, ALK Gene Rearrangement Positive Trial in United States (Ensartinib)
Available
- Non-Small Cell Lung Cancer
- ALK Gene Rearrangement Positive
-
Stanford, California
- +3 more
Oct 18, 2022
Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) Trial (Triheptanoin)
Available
- Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
- (no location specified)
Nov 22, 2022
Amyotrophic Lateral Sclerosis Trial in United States (NurOwn (MSC-NTF cells))
No longer available
- Amyotrophic Lateral Sclerosis
- NurOwn (MSC-NTF cells)
-
Irvine, California
- +4 more
Sep 13, 2022
Amyotrophic Lateral Sclerosis Trial in Puerto Rico, United States (AMX0035)
Approved for marketing
- Amyotrophic Lateral Sclerosis
-
Los Angeles, California
- +20 more
Oct 14, 2022
Critical COVID-19 With Respiratory Failure Trial in United States (ZYESAMI (aviptadil acetate))
No longer available
- Critical COVID-19 With Respiratory Failure
- ZYESAMI (aviptadil acetate)
-
Gilbert, Arizona
- +24 more
Jul 19, 2022
Prostatic Tumors, Prostatic Diseases, Prostate Cancer Trial in Portland (68GA PSMA-HBED-CC)
Approved for marketing
- Prostatic Neoplasms
- +4 more
- 68GA PSMA-HBED-CC
-
Portland, OregonOHSU Knight Cancer Institute
Mar 11, 2022
NF type1 With Inoperable Plexiform Neurofibromas Trial in New Orleans (Selumetinib)
Approved for marketing
- NF type1 With Inoperable Plexiform Neurofibromas
-
New Orleans, LouisianaResearch Site
Apr 30, 2020
Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19) Trial (Remestemcel-L,
Available
- Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)
- Remestemcel-L
- +2 more
- (no location specified)
Apr 12, 2022
Solid Organ Transplant Rejection, Organ Rejection Transplants, Organ Rejection Trial (Bone Marrow Mesenchymal Stem Cell Derived
Not yet recruiting
- Solid Organ Transplant Rejection
- +2 more
- Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment
- (no location specified)
Aug 16, 2022
